(Q31912887)

English

Combined effect of terazosin and finasteride on apoptosis, cell proliferation, and transforming growth factor-beta expression in benign prostatic hyperplasia

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

5 July 2017

Combined effect of terazosin and finasteride on apoptosis, cell proliferation, and transforming growth factor-beta expression in benign prostatic hyperplasia (English)

1 reference

Europe PubMed Central

PubMed publication ID

5 July 2017

prostatic hypertrophy

1 reference

based on heuristic

inferred from title

author name string

Glassman DT

1

1 reference

Europe PubMed Central

PubMed publication ID

5 July 2017

Chon JK

2

1 reference

Europe PubMed Central

PubMed publication ID

5 July 2017

Borkowski A

3

1 reference

Europe PubMed Central

PubMed publication ID

5 July 2017

Jacobs SC

4

1 reference

Europe PubMed Central

PubMed publication ID

5 July 2017

Kyprianou N

5

1 reference

Europe PubMed Central

PubMed publication ID

5 July 2017

publication date

1 January 2001

1 reference

Europe PubMed Central

PubMed publication ID

5 July 2017

1 reference

Europe PubMed Central

PubMed publication ID

5 July 2017

46

1 reference

Europe PubMed Central

PubMed publication ID

5 July 2017

1

1 reference

Europe PubMed Central

PubMed publication ID

5 July 2017

45-51

1 reference

Europe PubMed Central

PubMed publication ID

5 July 2017

Induction of prostate apoptosis by doxazosin in benign prostatic hyperplasia.

1 reference

https://api.crossref.org/works/10.1002%2F1097-0045%28200101%2946%3A1%3C45%3A%3AAID-PROS1007%3E3.0.CO%3B2-U

21 January 2018

The effect of finasteride on the risk of acute urinary retention and the need for surgical treatment among men with benign prostatic hyperplasia. Finasteride Long-Term Efficacy and Safety Study Group

1 reference

https://api.crossref.org/works/10.1002%2F1097-0045%28200101%2946%3A1%3C45%3A%3AAID-PROS1007%3E3.0.CO%3B2-U

21 January 2018

Dysregulated expression of growth factors and their receptors in the development of prostate cancer

1 reference

https://api.crossref.org/works/10.1002%2F1097-0045%28200101%2946%3A1%3C45%3A%3AAID-PROS1007%3E3.0.CO%3B2-U

21 January 2018

Vascular endothelial growth factor is up-regulated in vitro and in vivo by androgens

1 reference

https://api.crossref.org/works/10.1002%2F1097-0045%28200101%2946%3A1%3C45%3A%3AAID-PROS1007%3E3.0.CO%3B2-U

21 January 2018

Receptors for the TGF-β family

1 reference

https://api.crossref.org/works/10.1002%2F1097-0045%28200101%2946%3A1%3C45%3A%3AAID-PROS1007%3E3.0.CO%3B2-U

21 January 2018

TGF beta signals through a heteromeric protein kinase receptor complex

1 reference

https://api.crossref.org/works/10.1002%2F1097-0045%28200101%2946%3A1%3C45%3A%3AAID-PROS1007%3E3.0.CO%3B2-U

21 January 2018

Apoptotic versus proliferative activities in human benign prostatic hyperplasia

1 reference

https://api.crossref.org/works/10.1002%2F1097-0045%28200101%2946%3A1%3C45%3A%3AAID-PROS1007%3E3.0.CO%3B2-U

21 January 2018

The role of transforming growth factor-beta1, -beta2, and -beta3 in androgen-responsive growth of NRP-152 rat prostatic epithelial cells

1 reference

https://api.crossref.org/works/10.1002%2F1097-0045%28200101%2946%3A1%3C45%3A%3AAID-PROS1007%3E3.0.CO%3B2-U

21 January 2018

Hormonal control of programmed cell death/apoptosis

1 reference

https://api.crossref.org/works/10.1002%2F1097-0045%28200101%2946%3A1%3C45%3A%3AAID-PROS1007%3E3.0.CO%3B2-U

21 January 2018

Transforming growth factor beta 1 and its receptor types I and II. Comparison in human normal prostate, benign prostatic hyperplasia, and prostatic carcinoma

1 reference

https://api.crossref.org/works/10.1002%2F1097-0045%28200101%2946%3A1%3C45%3A%3AAID-PROS1007%3E3.0.CO%3B2-U

21 January 2018

Mechanism of activation of the TGF-beta receptor

1 reference

https://api.crossref.org/works/10.1002%2F1097-0045%28200101%2946%3A1%3C45%3A%3AAID-PROS1007%3E3.0.CO%3B2-U

21 January 2018

Correlation between proliferation, apoptosis, and angiogenesis in prostate carcinoma and their relation to androgen ablation.

1 reference

https://api.crossref.org/works/10.1002%2F1097-0045%28200101%2946%3A1%3C45%3A%3AAID-PROS1007%3E3.0.CO%3B2-U

21 January 2018

The efficacy of terazosin, finasteride, or both in benign prostatic hyperplasia. Veterans Affairs Cooperative Studies Benign Prostatic Hyperplasia Study Group

1 reference

https://api.crossref.org/works/10.1002%2F1097-0045%28200101%2946%3A1%3C45%3A%3AAID-PROS1007%3E3.0.CO%3B2-U

21 January 2018

Activation of programmed cell death in the rat ventral prostate after castration

1 reference

https://api.crossref.org/works/10.1002%2F1097-0045%28200101%2946%3A1%3C45%3A%3AAID-PROS1007%3E3.0.CO%3B2-U

21 January 2018

Morphological and hormonal changes in the ventral and dorsolateral prostatic lobes of rats treated with finasteride, a 5-alpha reductase inhibitor

1 reference

https://api.crossref.org/works/10.1002%2F1097-0045%28200101%2946%3A1%3C45%3A%3AAID-PROS1007%3E3.0.CO%3B2-U

21 January 2018

Expression of transforming growth factor-beta in the rat ventral prostate during castration-induced programmed cell death

1 reference

https://api.crossref.org/works/10.1002%2F1097-0045%28200101%2946%3A1%3C45%3A%3AAID-PROS1007%3E3.0.CO%3B2-U

21 January 2018

Transforming growth factor beta 1 transduced mouse prostate reconstitutions: II. Induction of apoptosis by doxazosin

1 reference

https://api.crossref.org/works/10.1002%2F1097-0045%28200101%2946%3A1%3C45%3A%3AAID-PROS1007%3E3.0.CO%3B2-U

21 January 2018

Transforming growth factor-beta1 up-regulates p15, p21 and p27 and blocks cell cycling in G1 in human prostate epithelium

1 reference

https://api.crossref.org/works/10.1002%2F1097-0045%28200101%2946%3A1%3C45%3A%3AAID-PROS1007%3E3.0.CO%3B2-U

21 January 2018

Prostate tissue composition and response to finasteride in men with symptomatic benign prostatic hyperplasia

1 reference

https://api.crossref.org/works/10.1002%2F1097-0045%28200101%2946%3A1%3C45%3A%3AAID-PROS1007%3E3.0.CO%3B2-U

21 January 2018

Effect of transforming growth factor-beta 1 on proliferation and death of rat prostatic cells

1 reference

https://api.crossref.org/works/10.1002%2F1097-0045%28200101%2946%3A1%3C45%3A%3AAID-PROS1007%3E3.0.CO%3B2-U

21 January 2018

Transforming growth factor beta I expression in benign and malignant prostatic tumors

1 reference

https://api.crossref.org/works/10.1002%2F1097-0045%28200101%2946%3A1%3C45%3A%3AAID-PROS1007%3E3.0.CO%3B2-U

21 January 2018

Regressive changes in finasteride-treated human hyperplastic prostates correlate with an upregulation of TGF-beta receptor expression

1 reference

https://api.crossref.org/works/10.1002%2F1097-0045%28200101%2946%3A1%3C45%3A%3AAID-PROS1007%3E3.0.CO%3B2-U

21 January 2018

Identification of a cellular receptor for transforming growth factor-beta in rat ventral prostate and its negative regulation by androgens

1 reference

https://api.crossref.org/works/10.1002%2F1097-0045%28200101%2946%3A1%3C45%3A%3AAID-PROS1007%3E3.0.CO%3B2-U

21 January 2018

Identifiers

10.1002/1097-0045(200101)46:1<45::AID-PROS1007>3.0.CO;2-U

1 reference

Europe PubMed Central

PubMed publication ID

5 July 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

5 July 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q31912887&oldid=1980117661"